Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RAIDEN RESOURCES LIMITED Interim / Quarterly Report 2005

Feb 14, 2005

65675_rns_2005-02-14_ba67fa69-61d0-4fe6-b35b-acfb4b5f41d2.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Notes for the Appendix 4C Monthly Report to 31 January 2005

MEDICAL MONITORS LIMITED (the "Company")

This note to the Appendix 4C MonthlyReport to 31 January 2005, is dealt in conjunction with the recent updated budget projection given to the ASX, dated 4 February 2004.

The revised sales projection and the associated costings provided, include sales from the recently announced Canadian venture, and a Private Placement of funds to be completed in February (as approved at the Annual General Meeting, 29 November 2004). The Private Placement has been made to sophisticated investors to provide sufficient funds particularly for the Company's international expansion and for inventory manufacture.

Importantly, with the budgeted export marketing grant monies, the sales revenue now expected in the March quarter and the increasing sales revenue and royalty stream anticipated over the coming months, the Directors believe that there is a sound financial base for the Company to continue with its current programs in Australia and overseas.

The Directors are confident of the continuing success for the Company's products and services in Australia and internationally, and will keep the market informed of any new developments.

Dr Allan Shell Managing Director

Medical Monitors Limited Suite 407 Office Tower Westfield Eastgardens Eastgardens NSW 2036 Australia Tel 02 9344 8100 Fax 02 9344 8200 www.medmon.com.au

$Rule 4.7B$

٦

Appendix 4C

Quarterly report for entities admitted on the basis of commitments

Introduced 31/3/2000. Amended 30/9/2001

Name of entity

Medical Monitors Limited

ABN

68 009 161 522

Month ended in current Quarter

31 JANUARY 2005

Consolidated statement of cash flows

Cash flows related to operating activities Current MonthSA'000 Year to date$\left( \frac{1}{2} \right)$ months)SA'000
1.1 Receipts from customers 10 382
$1.2\phantom{0}$ Payments for(a) staff costs (42) (393)
(b) advertising and marketing(c) research and development (39)(10) (264)(248)
(d) leased assets(e) other working capital (55) (372)
1.3 Dividends received
1.4 Interest and other items of a similar naturereceived $\overline{2}$
1.5 Interest and other costs of finance paid (2) (38)
1.6 Income taxes paid
1.7 Other (Govt Grants) 16 297
(122) (634)
Net onerating cash flows:

+ See chapter 19 for defined terms.

Current Month$A'000 Year to date$\binom{7}{1}$ months)$A'000
1.8 Net operating cash flows (carried forward) (122) (634)
Cash flows related to investing activities
1.9 Payment for acquisition of:
(a) businesses (item 5)
(b) equity investments (135)
(c) intellectual property
(d) physical non-
current assets
(e) other non-current (65)
assets
1.10 Proceeds from disposal of:(a) businesses (item $5$ )
(b)equity investments
(c) intellectual property
(d) physical non- 63
current assets
(e) other non-current 9
assets
150
1.11 Loans to other entities (65) (65)
1.12 Loans repaid by other entities $\overline{a}$
1.13 Other (provide details if material)
Net investing cash flows (65) (43)
1.14 Total operating and investing cash flows (187) (677)
Cash flows related to financing activities
1.15 Proceeds from issues of shares, options, etc. 150 535
1.16 Proceeds from sale of forfeited shares $\overline{\phantom{a}}$
1.17 Proceeds from borrowings 403
1.18 Repayment of borrowings (413)
1.19 Dividends paid
1.20 Other (Security Deposit)
Net financing cash flows 150 525
Net increase (decrease) in cash held (37) (152)
1.21 Cash at beginning of quarter/year to date 227 342
1.22 Exchange rate adjustments to item 1.20
1.23 Cash at end of quarter 190 190

+ See chapter 19 for defined terms.

Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities

Current Month$A'000
Aggregate amount of payments to the parties included in item 1.21.24 10
1.25Aggregate amount of loans to the parties included in item 1.11

1.26 Explanation necessary for an understanding of the transactions

Consultancy fees paid to research entities controlled by directors.

Non-cash financing and investing activities

  • $2.1$ Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows
  • $22$ Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

Financing facilities available

Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).

Amount available$A'000 Amount used$A'000
-3.1 Loan facilities
3.2 Credit standby arrangements 1000 Nil

+ See chapter 19 for defined terms.

Reconciliation of cash

Reconciliation of cash at the end of the quarter (asshown in the consolidated statement of cash flows) tothe related items in the accounts is as follows. Current Month$A'000 Previous quarter$A'000
4.1 Cash on hand and at hank 190 227
4.2 Deposits at call
4.3 Bank overdraft.
4.4 Other (provide details)
Total: cash at end of quarter (item 1.22) 190 -227

Acquisitions and disposals of business entities

Acquisitions(Item $1.9(a)$ ) Disposals(Item $1.10(a)$ )
5.1 Name of entity
-5.2 Place of incorporationor registration
5.3 Consideration foracquisition or disposal
5.4 Total net assets
5.5 Nature of business

Compliance statement

  • $\mathbf{1}$ This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.
  • This statement does give a true and fair view of the matters disclosed. $\overline{2}$

Sign here:

Date: 14 February 2005

Print name: Dr
m

Allan Shell (Director)

+ See chapter 19 for defined terms.

Notes

  • $11$ The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.
  • The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this $\overline{2}$ report except for the paragraphs of the Standard set out below.
    • $\bullet$ 62 - reconciliation of cash flows arising from operating activities to operating profit or loss
    • $9.2$ - itemised disclosure relating to acquisitions $\bullet$
    • 9.4 - itemised disclosure relating to disposals
    • $12.1(a)$ policy for classification of cash items
    • $12.3$ - disclosure of restrictions on use of cash
    • $13.1$ - comparative information $\bullet$
  • Accounting Standards. ASX will accept, for example, the use of International Accounting $\overline{3}$ . Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.

+ See chapter 19 for defined terms.